Beverly E. Girten

Person

Sunnyvale, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of erectile dysfunction using isoquinoline compound melan...
- Patent number 6,608,082
- Issue date Aug 19, 2003
- Lion bioscience AG
- Amaresh Basu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Melanocortin receptor-3 ligands to treat sexual dysfunction
- Patent number 6,534,503
- Issue date Mar 18, 2003
- Lion bioscience AG
- Kevin C. Dines
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Melanocortin receptor ligands and methods of using same
- Patent number 6,350,430
- Issue date Feb 26, 2002
- Lion Bioscience Science AG
- Colette T. Dooley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HP-3228 and related peptides to treat sexual dysfunction
- Patent number 6,284,735
- Issue date Sep 4, 2001
- Lion Bioscience AG
- Beverly E. Girten
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Cytokine restraining agents
- Patent number 6,245,738
- Issue date Jun 12, 2001
- Trega Biosciences, Inc.
- Mark J. Suto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoquinoline compound melanocortin receptor ligands and methods of...
- Patent number 6,127,381
- Issue date Oct 3, 2000
- Amaresh Basu
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Use of cytokine restraining agents to treat inflammatory bowel disease
- Patent number 5,888,969
- Issue date Mar 30, 1999
- Trega Biosciences, Inc.
- Beverly E. Girten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for reducing the severity of gastro-intestinal damage
- Patent number 5,888,978
- Issue date Mar 30, 1999
- Trega Biosciences, Inc.
- Beverly E. Girten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine restraining agents and methods of use in pathologies and c...
- Patent number 5,786,332
- Issue date Jul 28, 1998
- Trega Biosciences, Inc.
- Beverly E. Girten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine restraining agents and methods of use in pathologies and c...
- Patent number 5,760,001
- Issue date Jun 2, 1998
- Trega Biosciences, Inc.
- Beverly E. Girten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of a cytokine regulatory agent to treat rheumatoid arthritis
- Patent number 5,741,774
- Issue date Apr 21, 1998
- Trega Biosciences, Inc.
- Beverly E. Girten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine regulatory agents and methods of use in pathologies and co...
- Patent number 5,726,156
- Issue date Mar 10, 1998
- Trega Biosciences, Inc.
- Beverly E. Girten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of a substituted 1,3-benzodioxole to reduce a wasting condition
- Patent number 5,597,843
- Issue date Jan 28, 1997
- Houghten Pharmaceuticals
- Beverly E. Girten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine restraining agents
- Patent number 5,420,109
- Issue date May 30, 1995
- Houghten Pharmaceuticals, Inc.
- Mark J. Suto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Beverly E. Girten

Person

Patents Grantslast 30 patents

Treatment of erectile dysfunction using isoquinoline compound melan...

Melanocortin receptor-3 ligands to treat sexual dysfunction

Melanocortin receptor ligands and methods of using same

HP-3228 and related peptides to treat sexual dysfunction

Cytokine restraining agents

Isoquinoline compound melanocortin receptor ligands and methods of...

Use of cytokine restraining agents to treat inflammatory bowel disease

Method for reducing the severity of gastro-intestinal damage

Cytokine restraining agents and methods of use in pathologies and c...

Cytokine restraining agents and methods of use in pathologies and c...

Use of a cytokine regulatory agent to treat rheumatoid arthritis

Cytokine regulatory agents and methods of use in pathologies and co...

Use of a substituted 1,3-benzodioxole to reduce a wasting condition

Cytokine restraining agents